Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Clinical Considerations of the Surgical Closure of the PDA in the Premature Infants

미숙아 동맥관 개존증의 외과적 교정에 관한 임상적 고찰

  • 김상익 (가천의과대학부속길병원 흉부외과) ;
  • 박철현 (가천의과대학부속길병원 흉부외과) ;
  • 현성열 (가천의과대학부속길병원 흉부외과) ;
  • 김정철 (가천의과대학부속길병원 흉부외과) ;
  • 권진형 (가천의과대학부속길병원 마취과) ;
  • 박국양 (가천의과대학부속길병원 흉부외과)
  • Published : 1999.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Surgical closure of the PDA in premature infants with complications or contraindications to indomethacin use, or recurrence of symptomatic PDA is a safe and effective procedure with low operative risk and minimal complications. Material and Method: From April 1996 to August 1998, 11 premature infants with body weight under 1.5 kg at operation underwent operation for a symptomatic PDA (male:5, female: 6). Associated dise ases were congenital heart disease(7), hyaline membrane disease(6), intraventricular hemor rhage(4), pneumonia(4), pneumothorax(3), hyperbilirubinemia(2), necrotizing enterocolitis(2), renal failure(1), epilepsy(1), and hydrocephalus(1). Surgical techniques are hemoclipping(8) and ligation(3). The size of PDA was 3~6 mm (5.0$\pm$1.2). Result: Systolic and diastolic blood pressure rised and heart rates decreased after PDA closure. ABGA improved postoperatively. There were no surgical complications. Six infants with improved ABGA data were weaned from mechanical ventilatory support. The follow-up durations after discharge were 3 month to 12 month. Five deaths were not related to operation. The causes of death were hyaline membrane disease(2), bronchopulmonary dysplasia with pneumonia(1), sepsis(1), and con gestive heart failure with respiratory distress syndrome(1). Conclusion: Early operative closure is the treatment of choice in most premature infants with a hemodynamically significant shunt(PDA), recurrence of symptomatic PDA, complications of Indomethacin, or contraindi cations to Indomethacin.

배경: 미숙아 동맥관 개존증의 약물적 치료로 Indomethacin을 사용하는데 이때 발생하는 합병증, 부적응증, 또는 동맥관이 다시 열릴 경우 외과적으로 교정함으로써 수술에 따른 위험성 및 합병증이 적고 지속적인 동 맥관 폐쇄가 가능하다. 대상 및 방법: 1996년 4월부터 1998년 8월까지 동맥관 개존증을 동반한 미숙아중 수 술 당시의 체중이 1.5 kg 이하인 11명의 환아(남아: 5, 여아: 6)를 대상으로 하였다. 술전 동반질환으로 선천 성 심질환(7), 유리질막증(6), 폐렴(4), 뇌실내 출혈(4), 기흉(3), 고빌리루빈혈증(2), 괴사성 장염(2), 신부전증 (1), 간질(1), 수두증(1) 등이 있었다. 사용된 외과적 술식은 헤모클립을 사용한 경우(8)와 동맥관을 결찰한 경 우(3)가 있었다. 동맥관의 크기는 3~6 mm(5.0$\pm$1.2)였다. 결과: 동맥관을 폐쇄한후 수축기 및 확장기 혈압이 상승하였고 심박동수는 감소하였다. 동맥혈 개스 결과도 호전되었다. 수술과 관련된 합병증은 없었다. 술후 6명의 환아에서 호흡기 증상의 호전과 함께 인공호흡기이탈이 가능했고 모두 외래 추적 관찰중이다(3개월~ 12개월). 술후 5명의 환아가 사망하였는데 사망 원인은 유리질막증(2례), 기관지폐 이형성증과 폐렴(1례), 패 혈증(1례), 심부전증과 특발성 호흡곤란증(1례)이었다. 결론: Indomethacin에 부적응증 혹은 합병증이 있거나, Indomethacin용법에 효과가 없거나 또는 혈역학적으로 의미있는 단락을 동반하는 미숙아 동맥관의 우선 치료 법은 조기 외과적 교정술이다.

Keywords

References

  1. Pediatrics v.57 Incidence and clinical features of patent ductus arteriosus in low-birth wight infants: a prospective analysis of 150 consecutively born infants Siassi B;Blanco C;Cabal LA(et al.)
  2. J Pediatr v.111 Prevention of symptomtic PDA with a single dose of indomethacin Krueger E;Mellander M;Bratton D;Cotton R
  3. J Pediatr v.96 The contribution of PDA in the neonate with sever RDS Jacob J;Gluck L;DiSessa T(et al.)
  4. Lancet v.2 Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants and methylxanthines as prostaglandin agonists and antagonists Mankus MS;Horrobin DF
  5. Arch Dis Child v.71 Left ventricular preload reserve in preterm infants with patent ductus arteriosus Takahashi Y;Harada K;Ishida A(et al.)
  6. J Thorac Cardiovasc Surg v.83 Surgical and medical esperience with 734 premature infants with patent ductus arteriosus Mikhail M;Lee W;Toews W(Et al.)
  7. Br Heart J v.41 Failure of indomethacin to close persistent patent ductus arteriosus in infants weighing under 1000 grams Ivey HH;Kattwinkel J;Park TS(et al.)
  8. J Pediatr Surg v.22 Management of patent ductus arteriosus: A comparison of operative vs pharmacologic treatment Palder SB;Schwartz MZ;Tyson KRT(et al.)
  9. J Pediatr Surg v.18 Indomethacin versus immediate ligation in the treatment of 82 newborns with paent ductus arteriosus Zerella JT;Spies RJ;Denver DC(et al.)
  10. J Pediatr v.105 Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin Mellander M;Leheup B;Lindstrom DP(et al.)
  11. N Engl J Med v.295 Pharmacologic closure of patent ductus arteiosus in the premature infant Friedman WF;Hirschlau MJ;Printz MP(et al.)
  12. Ann Thorac Surg v.36 Manage-ment of patent ductus arteriosus in the premature infant: Indomethacin versus ligation Mavroudis C;Cook LN:Fleischaker BA(et al.)
  13. J Pediatr v.101 Physiologic changes associated with ligation of the ductus arteriosus in preterm infants Marshall JM;Marshall F Jr;Reddy PP
  14. J Pediatr v.93 Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease Naulty CM;Horn S;Conry J(et al.)
  15. Ann Thorac Surg v.46 Vocal cord paralysis in premature infants undergoing ductal closure Davis JT;Baciewicz FA;Suriyapa S(et al.)
  16. J Thorac Cardiovasc Surg v.98 Paralyzed left vocal cord associated with ligation of patent ductus arteriosus Fan LL;Campbell DN;Clarke DR(et al.)
  17. J Thorac Cardiovasc Surg v.87 Surgical closure of patent ductus arteriosus in 268 preterm infants Wagner HR;Ellison RC;Zierler S(et al.)
  18. Pediatrics v.73 Recurrence of patency of the ductus arteriosus after surgical ligation in premature infants Daniels SR;Reller MD;Kaplan S
  19. Pediatrics v.71 Ligation of patent ductus arteriosus in premature infants: Importance of accurate anatomic definition Fleming WH;Sarafian LB;Kugler JD(et al.)
  20. J Thorac Car-diovasc Surg v.82 Illusions leading to surgical closure of the distal left pulmonary artery instead of the ductus arteriosus Pontius RG;Danielson GK;Noonan JA(et al.)